BioPharmSignal logoBioPharmSignal

Biotech News

David F. Melbourne Jr. Promoted to Chief Executive Officer of AquaBounty; Sylvia Wulf to Continue as Non-Executive Board Chair

AquaBounty Technologies (AQB)AquaBounty TechnologiesCompany update

HARVARD, Mass., June 7, 2024 – The Board of Directors of AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance productivity and sustainability, today announced that David F. Melbourne Jr.

Related news

AQBAquaBounty Technologies2026-08-06 12:30 EST

AquaBounty Technologies Announces Expansion of Strategic Alternatives Review to Include Power Infrastructure Development Opportunities

AQBAquaBounty Technologies2025-10-28 12:00 EST

AquaBounty Technologies Announces Third Quarter 2025 Financial Results

View all latest news

AquaBounty Technologies

AquaBounty Technologies is an aquaculture company focused on genetically modified salmon production and food supply. Its business is about food technology and agricultural biotech rather than therapeutics.

Recent company news

AQBAquaBounty Technologies2026-08-06 12:30 EST

AquaBounty Technologies Announces Expansion of Strategic Alternatives Review to Include Power Infrastructure Development Opportunities

AQBAquaBounty Technologies2025-10-28 12:00 EST

AquaBounty Technologies Announces Third Quarter 2025 Financial Results

AQBAquaBounty Technologies2025-08-05 12:00 EST

AquaBounty Technologies Announces Second Quarter 2025 Financial Results

AQBAquaBounty Technologies2025-05-15 15:00 EST

AquaBounty Technologies Announces First Quarter 2025 Financial Results

AQBAquaBounty Technologies2025-03-27 12:00 EST

AquaBounty Technologies Announces Full Year 2024 Financial Results

Stock data

Close
1.31 USD
Market cap
5.15M USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States